Back to search
FDAFDA · Food and drugs·Recall number D-1058-2020

Pantoprazole Sodium Delayed-Release Tablets, USP, 40 mg, 90 count bottle, Rx Only, Manufactured by Jubilant Generics Ltd, Roorkee-247661 India, NDC 59746-284-90

Published March 25, 2020 · Recall initiated: March 11, 2020

Summary

FDA records drug Class II recall D-1058-2020, published March 25, 2020 and initiated March 11, 2020. Recalling firm: Jubilant Cadista Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 89,376 90-count bottles; Lot: Lot # PA218005A, exp. date 12/2020, PA218P010, PA218P011, exp. date 04/2021, PA218108A, PA218110A, exp. date 06/2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Presence of dark brown discoloration on edges of tablets

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Jubilant Cadista Pharmaceuticals, Inc.
Distributor
Distributed Nationwide in the USA
Lot
Lot # PA218005A, exp. date 12/2020, PA218P010, PA218P011, exp. date 04/2021, PA218108A, PA218110A, exp. date 06/2021
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Pantoprazole Sodium Delayed-Release Tablets, USP, 40 mg, 90 count bottle, Rx Only, Manufactured by Jubilant Generics Ltd, Roorkee-247661 India, NDC 59746-284-90 recalled?

Yes. FDA published recall D-1058-2020 on March 25, 2020. Reported hazard: CGMP Deviations: Presence of dark brown discoloration on edges of tablets

What should I do if I have this product?

Voluntary: Firm initiated · Letter